JPRN-UMIN000017975
Recruiting
未知
antiretroviral therapy regimen intensified with maraviroc during early HIV-1 infection - ART intensified by MVC with early HIV-1 infection
ational Hospital Organization Osaka National Hospital0 sites30 target enrollmentJune 19, 2015
ConditionsHIV-1 infection
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- HIV-1 infection
- Sponsor
- ational Hospital Organization Osaka National Hospital
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) coronary diseases: unstable angina or history of acute myocardial infarction within 6 months before entry 2\) Viral hepatitis (HBV,HCV) 3\) Any verified Grade 4 laboratory abnormality (excluding abnormal lipid metabolism) 4\)Alanine aminotransferase (ALT) greater than 5 times the upper limit of normal 5\) Subject has creatinine clearance of less than 50 mL/min via Cockroft\-Gault method 6\)Any evidence of primary viral resistance based on the presence of any major resistance\-associated mutation \[IAS\-USA, 2014] in the Screening result or, if known, any historical resistance test results 7\) Women who are pregnant or sexually active without effective contraception 8\) Subjects whom investigators consider to be inappropriate to enroll in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308
Completed
Not Applicable
Highly Active Antiretroviral Treatment (HAART) of Human Immunodeficiency Virus (HIV)-infection in a town in Cameroon: randomised controlled study to suggest which treatment starting point is most beneficial for the patientsHIV infectionInfections and InfestationsHIVISRCTN22114173Institute of Community Medicine, University of Tromsø (Norway)100
Completed
Not Applicable
Directly Observed antiretroviral Therapy for people living with Human Immunodeficiency Virus (HIV) and Acquired ImmunDeficiency Syndrome (AIDS): a randomised controlled trialISRCTN48682427Ministry of Health (Brazil)
Completed
Not Applicable
Impact of highly active anti-retroviral therapy (HAART) during pregnancy and breastfeeding on mother-to-child transmission (MTCT) and mother's healthHuman immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)Infections and InfestationsHuman immunodeficiency virus (HIV)ISRCTN71468401World Health Organization (WHO) (Switzerland)2,400
Not yet recruiting
Not Applicable
Promoting Adherence to Anti-retroviral Therapy and Viral suppression among HIV positive Young People in Uganda through Group Support PsychotherapyMental and Behavioural DisordersPACTR202006601935462CRI Foundation120